<--- Back to Details
First PageDocument Content
Canada / Health in Canada / Hospital for Sick Children / MaRS Discovery District
Date: 2009-11-27 16:31:16
Canada
Health in Canada
Hospital for Sick Children
MaRS Discovery District

Add to Reading List

Source URL: www.nce-rce.gc.ca

Download Document from Source Website

File Size: 221,63 KB

Share Document on Facebook

Similar Documents

2013 Annual Report HARNESSING A NEW ERA OF PARTNERSHIPS AND NETWORKS IN HEALTH INNOVATION THANK YOU TO OUR LEAD SPONSOR CANADA’S RESEARCH-BASED PHARMACEUTICAL COMPANIES

2013 Annual Report HARNESSING A NEW ERA OF PARTNERSHIPS AND NETWORKS IN HEALTH INNOVATION THANK YOU TO OUR LEAD SPONSOR CANADA’S RESEARCH-BASED PHARMACEUTICAL COMPANIES

DocID: 1vr6Q - View Document

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C   New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

DocID: 1vlwz - View Document

Postdoctoral Position in Computational Toxicology Co-hosted by CCAAM/CaCVAM, Health Canada, and Environment and Climate Change Canada   We are seeking a highly motivated and experienced Postdoctoral Research Fellow to

Postdoctoral Position in Computational Toxicology Co-hosted by CCAAM/CaCVAM, Health Canada, and Environment and Climate Change Canada   We are seeking a highly motivated and experienced Postdoctoral Research Fellow to

DocID: 1vlea - View Document

Community Support Contributions: 2014 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2014, we invested almost $6 million in health initiatives w

Community Support Contributions: 2014 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2014, we invested almost $6 million in health initiatives w

DocID: 1vkfE - View Document

PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes   

PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes   

DocID: 1vjI2 - View Document